Traditional Chinese pharmaceutical composition for treating ischemic stroke

Abstract

The invention provides a traditional Chinese pharmaceutical composition for treating ischemic stroke. The traditional Chinese pharmaceutical composition is prepared from active ingredients of radix astragali seu hedysari, radix puerariae lobatae, rhizoma chuanxiong, radix morindae officinalis, lumbricus, radix ophiopogonis, radix scutellariae, radix paeoniae rubra and radix dipsaci. The traditional Chinese pharmaceutical composition disclosed by the invention has the advantages of simple technology and controllable quality. The traditional Chinese pharmaceutical composition disclosed by the invention has the effects of reducing encephaledema, reducing brain vascular permeability, resisting oxygen deficit, dissolving fibrous protein by activating plasminogen, dissolving thrombus and the like. Meanwhile, the traditional Chinese pharmaceutical composition disclosed by the invention passes strict safety control like animal toxicity tests and the like, is suitable for ischemic stroke involving both collateral and meridian qi and yin deficiency, heat stasis collateral blocking syndrome, hemiplegia, mouth and tongue skew, sluggish speech, hemianesthesia, strength lack, dull red tongue, uneven pulse or sunken and string-like pulse and the like and has an obvious curative effect.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a combination of traditional Chinese medicines for treating ischemic stroke. Background technique [0002] Ischemic stroke has the characteristics of high morbidity, disability, mortality, and recurrence, and the incidence is still increasing year by year. Stroke is the second deadliest disease in the world, and 87% of strokes are ischemic strokes (thrombosis or embolism); in 2008, the third national cause of death survey by the Ministry of Health showed that the number of stroke deaths in my country (136.64 / 100,000 ) has exceeded the number of deaths from malignant tumors (135.88 / 100,000) as the leading cause of death; 1.5 million people die of stroke in my country every year, accounting for 51% of the total annual death causes; there are 6-7 million survivors, 40% Severely disabled, 70% lost the labor force to varying degrees. There are complex pathological changes ...

AI Technical Summary

Problems solved by technology

At present, Chinese patent medicines for the treatment of this disease are mostly based on qi deficiency and blood stasis. They are treated by nourishing qi and promoting blood circulation or medicines for promoting blood circulation (Buyang Huanwu Decoction, Naoxintong Capsule, Naofukang, Naoluoan, etc.), although they are curative, they are easy to aggravate the fever Blood stasis, easy to cause injury to yin and dryness, cerebral hemorrhage, cerebral ischemia-reperfusion injury and other disadvantages, the curative effect also needs to be improved

Images